| Literature DB >> 26261427 |
Catherine M Kress1, Lisa Sharling2, Ashli A Owen-Smith3, Dawit Desalegn4, Henry M Blumberg2, Jennifer Goedken1.
Abstract
BACKGROUND: Though cervical cancer incidence has dramatically decreased in resource rich regions due to the implementation of universal screening programs, it remains one of the most common cancers affecting women worldwide and has one of the highest mortality rates. The vast majority of cervical cancer-related deaths are among women that have never been screened. Prior to implementation of a screening program in Addis Ababa University-affiliated hospitals in Ethiopia, a survey was conducted to assess knowledge of cervical cancer etiology, risk factors, and screening, as well as attitudes and practices regarding cervical cancer screening among women's health care providers.Entities:
Keywords: Ethiopia; acetic acid; cervical cancer; cryotherapy; visual inspection
Year: 2015 PMID: 26261427 PMCID: PMC4527576 DOI: 10.2147/IJWH.S85138
Source DB: PubMed Journal: Int J Womens Health ISSN: 1179-1411
Demographics of participants
| Medical doctors | Medical students | Nurses and midwives | Total | |
|---|---|---|---|---|
| Age (years) | ||||
| <25 | 13 (15) | 46 (88) | 45 (23) | 104 (31) |
| 26–35 | 59 (70) | 6 (12) | 79 (40) | 144 (44) |
| 36–45 | 8 (10) | 0 (0) | 54 (27) | 62 (19) |
| ≥46 | 4 (5) | 0 (0) | 17 (9) | 21 (6) |
| Missing/unknown | 0 (0) | 0 (0) | 2 (1) | 2 (1) |
| Sex | ||||
| Male | 59 (70) | 27 (52) | 30 (15) | 116 (35) |
| Female | 25 (30) | 25 (48) | 167 (85) | 217 (65) |
| Setting | ||||
| Hospital | 81 (96) | 52 (100) | 174 (88) | 307 (92) |
| FGA clinic | 3 (4) | 0 (0) | 23 (12) | 26 (8) |
| Primary language | ||||
| Amharic | 65 (77) | 42 (81) | 152 (77) | 259 (78) |
| Oromia | 6 (7) | 6 (12) | 22 (11) | 34 (10) |
| Somali | 6 (7) | 2 (4) | 13 (7) | 21 (6) |
| Tigringa | 1 (1) | 0 (0) | 1 (1) | 2 (1) |
| Other | 4 (5) | 2 (4) | 3 (2) | 9 (3) |
| Missing/unknown | 2 (2) | 0 (0) | 6 (3) | 8 (2) |
| Religion | ||||
| Ethiopian Orthodox | 59 (70) | 38 (71) | 132 (66) | 227 (69) |
| Muslim | 9 (11) | 6 (12) | 25 (13) | 40 (12) |
| Protestant | 11 (13) | 6 (12) | 37 (19) | 54 (16) |
| Other | 4 (5) | 3 (6) | 1 (1) | 8 (2) |
| Missing/unknown | 1 (1) | 1 (2) | 2 (1) | 4 (1) |
| Number of years on the job | ||||
| <1 | 23 (27) | 2 (4) | 13 (7) | 38 (11) |
| 1–5 | 46 (55) | 26 (50) | 58 (29) | 130 (39) |
| 6–10 | 6 (7) | 24 (46) | 65 (33) | 95 (29) |
| >10 | 7 (8) | 0 (0) | 61 (31) | 68 (20) |
| Missing/unknown | 2 (2) | 0 (0) | 0 (0) | 2 (1) |
Notes:
Values are given as number (percentage);
physician’s specialty: obstetrics and gynecology =7 (2%); primary care physician (GP, internal medicine, pediatrics) =29 (9%); residents =48 (14%);
nurses =159 (48%) and midwives =38 (11%).
Abbreviation: FGA, Family Guidance Association.
Knowledge of cervical cancer etiology and prevention
| Question | Medical doctors | Medical students | Nurses and midwives | Total | |
|---|---|---|---|---|---|
|
| |||||
| Correct answer | |||||
| Cervical cancer is one of the leading causes of death in women worldwide – True | 73 (87) | 45 (87) | 153 (78) | 271 (81) | 0.038 |
| Cervical cancer is preventable – True | 82 (98) | 50 (96) | 151 (77) | 283 (85) | <0.001 |
| It is possible to detect pre-cancerous cervical cells – True | 77 (92) | 50 (96) | 162 (82) | 289 (87) | 0.019 |
| The purpose of screening for cervical cancer is to detect pre-cancerous changes – True | 83 (99) | 50 (96) | 171 (87) | 304 (91) | 0.012 |
| If untreated cervical cancer is fatal – True | 78 (93) | 47 (90) | 152 (77) | 277 (83) | 0.016 |
| Cervical cancer is caused by a virus that is spread sexually – True | 78 (93) | 46 (88) | 63 (32) | 187 (56) | <0.001 |
| There is a vaccine that can prevent cervical cancer – True | 64 (76) | 23 (44) | 36 (18) | 123 (37) | <0.001 |
| Cervical cancer is not curable – False | 56 (87) | 28 (54) | 88 (45) | 172 (52) | 0.013 |
| Cervical cancer is most common among women in their 20s – False | 78 (93) | 40 (77) | 133 (68) | 251 (75) | <0.001 |
| For cervical cancer, the progression of pre-cancerous cells to cancer can take 10–20 years – True | 78 (93) | 41 (79) | 70 (36) | 189 (57) | <0.001 |
| Cervical cancer can usually be found at an early stage because of the obvious symptoms – False | 66 (79) | 30 (58) | 85 (43) | 181 (54) | <0.001 |
Notes:
Values are given as number (percentage);
difference in knowledge between group.
Knowledge of risk factors for cervical cancer
| Question | Medical doctors (n=84) | Medical students (n=52) | Nurses and midwives (n=197) | Total | |
|---|---|---|---|---|---|
|
| |||||
| Correct answer | |||||
| Correctly identified all four risk factors | 59 (70) | 25 (48) | 70 (36) | 156 (47) | <0.001 |
| Infection with the human immunodeficiency virus (HIV) | 78 (93) | 39 (75) | 123 (62) | 240 (72) | <0.001 |
| Infection with human papilloma virus (HPV) | 81 (96) | 48 (92) | 147 (75) | 276 (83) | <0.001 |
| Having multiple sex partners | 80 (95) | 47 (90) | 135 (69) | 262 (79) | <0.001 |
| Smoking cigarettes | 64 (76) | 34 (65) | 118 (60) | 216 (65) | 0.032 |
| Misidentified at least one non-risk factor | 23 (27) | 35 (67) | 120 (61) | 179 (54) | <0.001 |
| Poor personal hygiene | 19 (23) | 29 (56) | 102 (52) | 150 (45) | <0.001 |
| Use of intrauterine devices (IUDs) | 6 (7) | 19 (37) | 32 (16) | 57 (17) | <0.001 |
| Use of herbal remedies | 5 (6) | 7 (13) | 59 (30) | 71 (21) | <0.001 |
| Use of tampons | 5 (6) | 9 (17) | 26 (13) | 40 (12) | 0.102 |
Notes:
Values are given as number (percentage);
difference in knowledge between groups.
Attitudes, awareness, and experiences related to cervical cancer screening
| Question | Medical doctors | Medical students | Nurses and midwives | Total | |
|---|---|---|---|---|---|
|
| |||||
| Strongly agree/agree | |||||
| Cervical cancer screening is an essential part of women’s health care | 84 (100) | 50 (96) | 184 (95) | 329 (97) | 0.136 |
| Cervical cancer is a very serious disease | 84 (100) | 52 (100) | 184 (96) | 320 (98) | 0.055 |
| A cervical cancer screening program should be started in my community | 84 (100) | 49 (94) | 158 (83) | 291 (89) | <0.001 |
| Female respondents | |||||
| Have you ever received a pap smear | 8 (32) | 0 (0) | 29 (18) | 37 (17) | 0.035 |
| Have you ever heard of the following tests | |||||
| Pap smear | 80 (95) | 51 (98) | 175 (89) | 306 (92) | 0.041 |
| Human papilloma virus DNA testing | 72 (86) | 40 (77) | 69 (35) | 181 (54) | <0.001 |
| Liquid-based cytology | 55 (65) | 19 (37) | 41 (21) | 115 (35) | <0.001 |
| Visual inspection with acetic acid | 69 (82) | 31 (60) | 62 (31) | 163 (49) | <0.001 |
| Visual inspection with Lugol’s solution | 68 (81) | 37 (71) | 51 (26) | 156 (47) | <0.001 |
| Have you ever diagnosed a patient with cervical cancer | 33 (42) | 7 (14) | 29 (15) | 69 (22) | <0.001 |
| Have you ever diagnosed pre-cancerous cervical lesions in a patient | 56 (67) | 10 (19) | 52 (27) | 118 (36) | <0.001 |
| Have you ever treated pre-cancerous cervical lesions in a patient | 26 (31) | 5 (10) | 26 (14) | 57 (18) | <0.001 |
Notes:
The 5-point scale eliciting the answers “strongly agree”, “agree”, “no opinion”, “disagree” and “strongly disagree” was dichotomized to “strongly agree” or “agree” versus “no opinion”, “disagree” or “strongly disagree”; values are given as number (percentage);
difference between groups;
four missing values for nurses/midwives;
five missing values for nurses and midwives;
seven missing values for nurses/midwives;
216 female respondents, one missing value for nurses and midwives;
four missing values for nurses and midwives;
three missing values for nurses and midwives;
one missing value for medical doctors and six missing values for midwives.
Perceived barriers to providing cervical cancer screening
| Question | Medical doctors | Medical students | Nurses and midwives | Total | No answer | |
|---|---|---|---|---|---|---|
|
| ||||||
| “Quite a bit” or “a lot” of barrier(s) | ||||||
| My patients dislike/refuse screening | 8 (10) | 11 (30) | 22 (13) | 41 (15) | 0.016 | 52 (16) |
| My patients have more pressing health problems | 32 (41) | 15 (43) | 54 (34) | 101 (37) | 0.390 | 59 (18) |
| I have not had the necessary training in order to screen | 37 (47) | 21 (49) | 80 (55) | 148 (52) | 0.491 | 46 (14) |
| The screening tests are too expensive for patients | 31 (39) | 14 (37) | 75 (44) | 120 (42) | 0.590 | 47 (14) |
| I do not have enough time/I am too busy to screen | 9 (12) | 7 (19) | 27 (16.4) | 43 (15) | 0.532 | 53 (16) |
| I do not have the necessary equipment/supplies | 45 (57) | 20 (56) | 79 (50) | 144 (53) | 0.593 | 61 (18) |
| The screening procedures are too difficult | 9 (12) | 5 (14) | 37 (24) | 51 (19) | 0.066 | 65 (20) |
| I do not have the necessary laboratory resources to screen | 36 (47) | 15 (41) | 60 (39) | 111 (41) | 0.452 | 65 (20) |
| I do not have the capacity to follow-up patients after screening | 27 (35) | 16 (45) | 56 (36) | 99 (37) | 0.605 | 66 (20) |
Notes:
The 4-point scale eliciting the answers “not at all”, “somewhat”, “quite a bit” and “a lot” was dichotomized to “not at all” or “somewhat” versus “quite a bit” or “a lot” where values are given as number (percentage);
difference between groups;
missing values for five doctors, 15 medical students, and 32 nurses and midwives;
missing values for six doctors, 17 medical students, and 36 nurses and midwives;
missing values for five doctors, nine medical students, and 32 nurses and midwives;
missing values for five doctors, 14 medical students and 28 nurses and midwives;
missing values for seven doctors, 15 medical students, and 31 nurses and midwives;
missing values for five doctors, 16 medical students and 40 nurses and midwives;
missing values for seven doctors, 17 medical students and 41 nurses and midwives;
missing values for eight doctors, 15 medical students and 42 nurses and midwives;
missing values for ten doctors, 16 medical students and 43 nurses and midwives.
Figure 1Number of cervical cancer screening procedures performed by provider type.
Note: Proportion of medical doctors, medical students and nurses and midwives having performed pap smear, visual inspection with acetic acid (VIA) or visual inspection with Lugol’s iodine (VILI).